XML 51 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Contingent Consideration Payable and Royalty Payments (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 31, 2024
Sep. 30, 2025
Sep. 30, 2025
Additional Paid-in Capital      
Asset Acquisition [Line Items]      
Stock issued during period value acquisitions     $ 5.9
ImmPACT Bio USA Inc.      
Asset Acquisition [Line Items]      
Asset acquisition, upfront payment $ 30.0    
Cash acquired from acquisition $ 11.9    
Stock issued during period, shares, acquisitions (in shares) 1,875,000    
Asset acquisition, contingent consideration arrangements, entity shares issuable (in shares) 625,000   625,000
Asset acquisition, contingent consideration, fair value remeasurement, (loss) gain   $ (0.4) $ 1.7